ProPhase Labs Inc. to Present Second Quarter 2025 Financial Results on August 13, 2025
Rhea-AI Summary
ProPhase Labs (NASDAQ:PRPH), a biotech, genomics and consumer products company, has scheduled its second quarter 2025 financial results presentation for August 13, 2025, at 2:00 pm EDT. The company will host a virtual conference call through Renmark Financial, with financial results to be released via press release before the call.
Stakeholders and investors can attend the live event by registering through Renmark Financial's platform. A replay of the presentation will be made available on ProPhase's investor website after the event.
Positive
- None.
Negative
- None.
News Market Reaction – PRPH
On the day this news was published, PRPH declined 9.77%, reflecting a notable negative market reaction. Argus tracked a peak move of +38.0% during that session. Argus tracked a trough of -18.9% from its starting point during tracking. Our momentum scanner triggered 22 alerts that day, indicating elevated trading interest and price volatility. This price movement removed approximately $2M from the company's valuation, bringing the market cap to $18M at that time. Trading volume was exceptionally heavy at 255.5x the daily average, suggesting significant selling pressure.
Data tracked by StockTitan Argus on the day of publication.
UNIONDALE, NY, Aug. 11, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, announced today that they will be presenting second quarter 2025 financial results on a virtual conference call hosted by Renmark Financial on August 13, 2025, at 2:00 pm EDT.
A press release detailing these results will be issued prior to the virtual conference call. ProPhase Labs Inc. welcomes stakeholders, investors, and other individual followers to register and attend this live event.
Investors interested in participating in this live event will need to register using the link below. After the event, a replay will be available on The Company’s investor website.
REGISTER HERE: https://www.renmarkfinancial.com/events/second-quarter-2025-results-virtual-conference-call-nasdaq-prph-wUOjCShxnL
- To ensure smooth connectivity, please access this link using the latest version of Google Chrome.
About ProPhase Labs Inc.
ProPhase Labs Inc. (Nasdaq: PRPH) (“ProPhase”) is a next-generation biotech, genomics and consumer products company. Our mission is to build a healthier world through bold innovation and actionable insight. We’re revolutionizing healthcare with industry-leading Whole Genome Sequencing solutions, groundbreaking diagnostic development – such as our potentially life-saving test for the early detection of esophageal cancer – and a world class direct-to-consumer marketing platform for cutting edge OTC dietary supplements. We develop, manufacture, and commercialize health and wellness solutions to enable people to live their best lives. We are committed to executional excellence, smart diversification, and a synergistic, omni-channel approach. ProPhase Labs’ valuable subsidiaries, their synergies, and significant growth underscore our potential for long-term value. www.ProPhaseLabs.com
Media Relations and Institutional Investor Contact:
ProPhase Labs, Inc.
investorrelations@prophaselabs.com
Retail Investor Relations Contact:
Renmark Financial Communications Inc.
John Boidman: jboidman@renmarkfinancial.com
Tel.: (416) 644-2020 or (212) 812-7680
www.renmarkfinancial.com
FAQ
When will ProPhase Labs (PRPH) release Q2 2025 earnings?
How can investors access ProPhase Labs' Q2 2025 earnings call?
What will ProPhase Labs discuss in their Q2 2025 earnings call?
What browser should I use to access ProPhase Labs' Q2 earnings call?
